# Myrbetriq

NDC: 0469-5020
Generic name: mirabegron
Labeler / Manufacturer: Astellas Pharma US, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: GRANULE, FOR SUSPENSION, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20210325

FDA application: NDA213801

## Active ingredients

- MIRABEGRON: 8 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0469-5020"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0469-5020
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ba9e9e15-e666-4c56-9271-2e24739cfa2d